
A look at the biotech companies that closed funding rounds in March 2026 — from cancer T-cell engagers to AI-driven antibody design. What these raises reveal about where the industry is headed and what investors are betting on.

Biotech Companies That Raised Funding in March 2026

Why Biotech Labs Are Replacing Spreadsheets in 2026 — And What They're Moving To

How to Manage a Cell Therapy Lab: Data, Samples, and Scale

The Biggest Challenges Facing Biotech Labs in 2026 — And How Leading Teams Are Solving Them

Best Lab Management Software for Biotech Startups in 2026

How Biotech Labs Are Using AI in 2026 — And What Data Infrastructure They Need First